2019
DOI: 10.3892/ol.2019.10342
|View full text |Cite|
|
Sign up to set email alerts
|

High‑resolution melting analysis for rapid and sensitive MYD88 screening in chronic lymphocytic leukemia

Abstract: High resolution melting (HRM) assay is a novel technology for the fast, high-throughput, sensitive, post-PCR analysis of genetic mutations. Myeloid differentiation primary response 88 (MYD88) mutations are frequently reported in chronic lymphocytic leukemia (CLL) and confer a worse prognosis. The objective of the present study was to assess the value of HRM analysis for the rapid screening of MYD88 mutations in patients with CLL. Genomic DNA samples were extracted from the bone marrow of 129 newly diagnosed pa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 36 publications
0
4
0
Order By: Relevance
“…Although direct sequencing and NGS detect various mutations, their sensitivity is notably low, typically in the range of 1%-10%. [11,29] Digital PCR, a recently developed method with enhanced sensitivity (0.01%), requires numerous primers for the detection of various mutations. [11,30] In contrast, our assay method showed remarkable sensitivity of 1 Â 10 À9 %, surpassing that of digital PCR by 10 7 -fold.…”
Section: Clinical Sample Test Using Plasma Samplesmentioning
confidence: 99%
“…Although direct sequencing and NGS detect various mutations, their sensitivity is notably low, typically in the range of 1%-10%. [11,29] Digital PCR, a recently developed method with enhanced sensitivity (0.01%), requires numerous primers for the detection of various mutations. [11,30] In contrast, our assay method showed remarkable sensitivity of 1 Â 10 À9 %, surpassing that of digital PCR by 10 7 -fold.…”
Section: Clinical Sample Test Using Plasma Samplesmentioning
confidence: 99%
“…83 Furthermore, MYD88(L265P) is absent in primary mediastinal large Bcell lymphoma 2,3,94 and primary cutaneous follicle center lymphoma, [71][72][73] and rarely present in hairy cell leukemia (1.1%), 22,30,[57][58][59] plasma cell myeloma (1.5%), 18,22,23,43,106,107 Burkitt lymphoma (1.5%), 2,74 follicular lymphoma (1.9%), 18,22,23,67,68 and CLL (2.5%). 18,[22][23][24]28,[38][39][40][41][42][43][44][45][46][47][48][49][50][51][52]…”
Section: Prevalencementioning
confidence: 99%
“…This approach has several notable advantages such as reducing the chances of cross-contamination and the fact that it does not require the handling of hazardous materials ( Erdem et al, 2016 ; Gopaul et al, 2014 ). Additionally, it is recognized as being less time-consuming ( Jiang et al, 2019 ). Besides, specimens could be distinguished by graph changes in the melting curves that are generated by HRM and are easily visualized ( Jin et al, 2014 ).…”
Section: Introductionmentioning
confidence: 99%